Mechanism of Anti-HIV Activity of Negatively Charged Albumins: Biomolecular Interaction with the HIV-1 Envelope Protein gp120
- 15 April 1996
- journal article
- basic science
- Published by Wolters Kluwer Health in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 11 (5) , 419-429
- https://doi.org/10.1097/00042560-199604150-00001
Abstract
Summary: A novel class of polyanionic proteins with potent anti-human immunodeficiency virus type 1 activity, the negatively charged albumins (NCAs), have been reported previously. In vitro antiviral assays established that these compounds preferentially inhibit virus-cell fusion and syncytium formation and that virus-cell binding is less affected. Here the interaction of the NCAs with synthetic peptides composed of 15-36 amino acids and corresponding to different parts of the gp120 envelope protein is described. Among the gp120 peptides tested, binding of the NCAs was observed only with the so-called V3 loop (amino acids 296-330) and the C-terminal part of gp120. A higher number of negatively charged residues in the albumins resulted in higher binding affinities. NCAs in which, in addition to negative charges, up to 7 or 14 lactose or mannose groups were introduced, respectively, did not exhibit increasing binding affinity. In contrast, mannosylated albumin containing about 14 mannose groups showed an increased binding compared with native albumin. Binding of the NCAs to the V3 and C-terminal oligopeptide was competitively inhibited by sulfated polysaccharide heparin and dextran sulfate. This finding indicates that the binding between the gp120 peptides and the NCAs is likely caused by electrostatic interactions. However, the fact that the dissociation constants of dextran sulfate and heparin are orders of magnitude larger compared with the NCAs indicates that the spatial structure of the proteins and/or hydrophobic interactions between the NCAs and the envelope protein may also be involved.Keywords
This publication has 49 references indexed in Scilit:
- Effect of sialic acid removal on the antibody response to the third variable domain of human immunodeficiency virus type‐1 envelope glycoproteinFEBS Letters, 1994
- The Amino-Terminal Peptide of HIV-1 gp41 Interacts with Human Serum AlbuminAIDS Research and Human Retroviruses, 1993
- The interaction of a glycosaminoglycan heparin, with HIV-1 major envelope glycoproteinBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1992
- Mannosyl/N-acetyl-β-D-glucosaminyl binding properties of the envelope glycoprotein of human immunodeficiency virus type 2Glycobiology, 1992
- Differential Tropism of Clinical HIV-1 Isolates for Primary Monocytes and Promonocytic Cell LinesAIDS Research and Human Retroviruses, 1992
- Studies on the Role of the V3 Loop in Human Immunodeficiency Virus Type 1 Envelope Glycoprotein FunctionAIDS Research and Human Retroviruses, 1992
- Formaldehyde treated albumin contains monomeric and polymeric forms that are differently cleared by endothelial and kupffer cells of the liver: Evidence for scavenger receptor heterogeneityBiochemical and Biophysical Research Communications, 1991
- T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAVNature, 1984
- The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirusNature, 1984
- THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONSAnnals of the New York Academy of Sciences, 1949